Research recommendation(s) from an individual piece of guidance
- Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura
- Date issued:
Research recommendations coming out of this guidance
- NICE recommends that research should be carried out to directly compare eltrombopag with non-thrombopoietin receptor agonist treatments routinely used in UK clinical practice.
- NICE recommends research generating and analysing observational data including, but not limited to, the existing UK ITP Registry, which collects data on the long-term outcomes of patients treated with eltrombopag and romiplostim.